Preview

Russian neurological journal

Advanced search

CLINICAL LABORATORY AND MOLECULAR GENETIC DIAGNOSIS OF WILSON-KONOVALOV DISEASE

https://doi.org/10.30629/2658-7947-2019-24-3-10-18

Abstract

Introduction. The clinical picture of Wilson-Konovalov disease (WKD) is characterized by pronounced polymorphism and classical laboratory findings often do not allow to make diagnosis. The most reliable way to confirm the presence of WKD is to identify mutations in the ATP7B gene. Materials and methods. In the course of the research, we developed a method of genetic diagnostics, including realtime PCR to determine a point mutation in combination with fragment analysis to identify deletions and insertions. 20 patients were collected in whom the diagnosis of WKD was made basing on the results of clinical and laboratory criteria of the disease according to the Leipzig scoring system. All patients were genotyped with the developed technique. Anamnestic, clinical, and laboratory data were collected for 12 patients. Results. We detected the following aberrancies in patients from the group 1: heterozygous mutations according to H1069Q (60%), homozygous mutations according to H1069Q (30%), combination of mutations 3627_3630del.4/ H1069Q in heterozygous form (5%), combination of mutations1770insT/H1069Q in heterozygous form (5%). Discussion. Clinical feature of WKD is non-specific, and the combination of liver and nervous system damage typical for WKD, Kayser–Fleischer rings are far from being present in all patients or appear in the later stages of the disease. A considerable amount of false-negative results of WKD laboratory markers indicates the insufficient sensitivity of these research methods. The variability of clinical and laboratory markers of WKD delays the etiology diagnosis and the onset of pathogenetic therapy. Conclusion. The developed method of genetic diagnosis of WKD is recommended for all patients of the Russian population with suspected hepatic, neurological or mixed form of WKD in order to make a timely diagnosis and start treatment.

About the Authors

E. A. Gerner
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of Russian Federation
Russian Federation
student of 6th year


V. D. Nazarov
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of Russian Federation
Russian Federation
Research Fellow, Laboratory of Autoimmune Diagnostics, Center for Molecular Medicine


T. F. Fedorova
Federal State Budgetary Healthcare Institution «St. Petersburg clinical hospital of the Russian Academy of Sciences»
Russian Federation
PhD (Medicine), Head


S. V. Lapin
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of Russian Federation
Russian Federation
PhD (Medicine), Head, Laboratory of Autoimmune Diagnostics, Center for Molecular Medicine


T. A. Pavlova
Federal State Budgetary Institution «Almazov National Medical Research Centre» of the Ministry of Health of the Russian Federation
Russian Federation
Head, neurology department №1, Neurologist


S. A. Novikov
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of Russian Federation
Russian Federation
PhD, MD (Medicine), Professor of ophthalmology department


T. M. Alekseeva
Federal State Budgetary Institution «Almazov National Medical Research Centre» of the Ministry of Health of the Russian Federation
Russian Federation
PhD, MD (Medicine), Head, neurology department №3, Neurologist


V. L. Emanuel
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, Head, Department of Clinical Laboratory Diagnostics with a Course of Molecular Medicine


E. B. Panina
Federal State Budgetary Institution «Almazov National Medical Research Centre» of the Ministry of Health of the Russian Federation
Russian Federation
PhD (Medicine), associate Professor of neurology and psychiatry, Neurologist


References

1. P de Bie, P Muller, C Wijmenga, L W J Klomp Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. Journal of Medical Genetics. 2007;44(11):673-688. DOI: 10.1136/ jmg.2007.052746.

2. Ala A., Walker A.P., Ashkan K., Dooley J.S., Schilsky M.L. Wilson’s disease. The Lancet. 2007;369 (9559):397-408. DOI: 10.1016/S0140-6736(07)60196-2.

3. Bayazutdinova G.M., Shchagina O.A. Molecular pathogenesis of Wilson-Konovalov disease. Meditsinskaya genetika. 2017;16(7):18-24. (in Russian)

4. Golubeva V.V., Mazurchik N.V., Garabova N.I., Nozdryukhina N.V., Strutsenko A.A. Two cases of Wilson-Konovalov disease. Nevrologiya, neyropsikhiatriya, psikhosomatika. 2013;(3):41–46. (in Russian)]. DOI: 10.14412/2074-2711-2013-2339.

5. Lutsenko S., Barnes N.L., Bartee M.Y. and Dmitriev O.Y. Function and regulation of human copper-transporting ATPases. Physiological Reviews. 2007;87(3):1011-1046. DOI: 10.1152/ physrev.00004.2006.

6. Balashova M.S., Solov’eva O.V., Fastovets S.V., Tuluzanovskaya I.G., Filimonov M.I., Bayazutdinova G.M. et al. The clinical value of sequencing of the ATP7B gene in the diagnosis of Wilson-Konovalov disease. Meditsinskaya genetika. 2016;15(7):14-16. (in Russian)]. DOI: 10.1234/ XXXX-XXXX-2016-7-14-16.

7. Panagiotakaki E., Tzetis M., Manolaki N., Loudianos G., Athanasios P., Manesis E. et al. Genotype–Phenotype Correlations for a Wide Spectrum of Mutations in the Wilson Disease Gene (ATP7B). American Journal of Medical Genetics. 2004; 131A (2):168-173. DOI: 10.1002/ajmg.a.30345.

8. Stapelbroek J., Bollen C., van Amstel P., van Erpecum K., van Hattum J., van den Berg L., Klomp L., Houwen R. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. Journal of Hepatology. 2004;41(5):758–763. DOI: 10.1016/j. jhep.2004.07.017.

9. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson Disease: impact on genetic testing. Human Genetics. 2006;120(2):151-159. DOI: 10.1007/s00439-006-0202-5.

10. Eremina E. Yu. Wilson-Konovalov disease. Vestnik sovremennoy klinicheskoy meditsiny. 2011;4(1):38-46. (in Russian)

11. Gow P.J., Smallwood R.A., Angus P.W, Smith A.L, Wall A.J., Sewell R.B. Diagnosis of Wilson’s disease: an experience over three Decades. Gut. 2000;46(3):415-419. DOI: 10.1136/ gut.46.3.415.

12. Perri R.E., Hahn S.H., Ferber M.J., Kamath P.S. Wilson Diseasekeeping the bar for diagnosis raised. Hepatology.2005;42(4):974. DOI: 10.1002/hep.20893.

13. Kozlova N.M., Gvak K.V., Gadzhibalaeva L. Sh. Wilson-Konovalov disease. Sibirskiy meditsinskiy zhurnal. 2011;104(5):125-129. (in Russian)

14. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., Schilsky M., Cox D., Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver International. 2003;23(3):139-142. DOI: 10.1034/j.1600-0676.2003.00824.x.

15. Roberts E.A., Schilsky M.L. A practice guideline on Wilson disease. Hepatology. 2003;37(6):1475-1492. DOI: 10.1053/ jhep.2003.50252.

16. Tanzi R.E., Petrukhin K., Chernov I., Pellecuer J.L., Wasco W., Ross B. et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genetics. 1993;5(4):344-350. DOI: 10.1038/ng1293-344.

17. Walshe J.M. Wilson’s disease: the importance of measuring serum caeruloplasmin non-immunologically. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2003;40(2):115-121. DOI: 10.1258/000456303763046021.

18. Jawdat N. Gaaib, Adnan F. Nassief. And Akeel H. Al-Assi Simple salting – out method for genomic DNA extraction from whole blood. Tikrit Journal of Pure Science. 2011;16(2):1813-662.

19. Bayazutdinova G.M., Shchagina O.A., Polyakov A.V. The mutation p. 3207C> A of the ATР7B gene is the most common cause of hepatolenticular degeneration in Russia: frequency and cause of spread. Meditsinskaya genetika. 2018;17(4):25-30. (in Russian)] DOI: 10.25557/2073-7998.2018.04.25-30.

20. Asanov A.Yu., Sokolov A.A., Volgina S.Ya., Goryacheva L.G., Gustov A.V, Ivanova-Smolenskaya I.A. et al. Federal clinical guidelines for the diagnosis and treatment of Wilson-Konovalov disease (hepatolenticular degeneration). Moscow – 2015:5-71. (in Russian)

21. Ferenci P., Czlonkowska A., Stremmel W., Houwen R., Rosenberg W., Schilsky M.. EASL Clinical Practice Guidelines: Wilson’s disease. Journal of Hepatology. 2012;56 (3):671-685. DOI: 10.1016/j.jhep.2011.11.007.

22. Zalyalova Z.A. Modern approaches to the diagnosis and treatment of Wilson-Konovalov disease. Kazanskiy meditsinskiy zhurnal. 2003;82(2):154-155. (in Russian)

23. Pilloni L., Lecca S., Coni P., Demelia L., Pilleri G., Spiga E. et al. Wilson’s disease with late onset. Digestive and Liver Disease. 2000;32(2):180. DOI: 10.1016/S1590-8658(00)80408-9.

24. Mishchenko T.S., Voloshin-Gaponov I.K. Modern aspects of Wilson’s disease. Mezhdunarodnyy nevrologicheskiy zhurnal. 2015;2 (72):20-23. (in Russian)

25. Egorova A.T., Bazina M.I., Maiseenko D.A., Kiseleva E.Yu., Tsaryuk E.P. Wilson-Konovalov disease and pregnancy. Sibirskoe meditsinskoe obozrenie. 2014;1(85):89-92. (in Russian)

26. Sharma S., Toppo A., Rath B., Harbhajanka A., Lalita Jyotsna P. Hemolytic Anemia as a Presenting Feature of Wilson’s Disease. Indian Journal of Hematology and Blood Transfusion. 2010;26(3):101–102. DOI: 10.1007/s12288-010-0034-2.

27. Mel’nikova M.Yu., Fedorova T.F., Lobzin S.V., Panina E.B., Stel’makh V.V., Nekrasova A.S. et al. Hemorrhagic syndrome in hepatolenticular degeneration: clinical features. Nevrologicheskiy zhurnal. 2014;19(6):23-30. (in Russian)

28. Baranov A.A., Namazova-Baranova L.S., Potapov A.S., Polyakova S.I., Tsymbalova E.G., Chetkina T.S. Federal clinical guidelines for the provision of medical care for children with Wilson’s disease. Moscow – 2015; 3-21. (in Russian)

29. Suhareva G.V. Hepatolenticular degeneration and variants of liver damage. Lechenie i profilaktika. 2012;2(3):36-41. (in Russian)

30. Denisova M.F., Donde S.M., Dyba M.B., Muzyka N.N., Reminnaya N.T., Chernega N.V. Clinical variants of the hepatic form of Wilson-Konovalov disease in children. Perinatologiya i pediatriya. 2013;3(55):70-73. (in Russian)


Review

For citations:


Gerner E.A., Nazarov V.D., Fedorova T.F., Lapin S.V., Pavlova T.A., Novikov S.A., Alekseeva T.M., Emanuel V.L., Panina E.B. CLINICAL LABORATORY AND MOLECULAR GENETIC DIAGNOSIS OF WILSON-KONOVALOV DISEASE. Russian neurological journal. 2019;(3):10-18. (In Russ.) https://doi.org/10.30629/2658-7947-2019-24-3-10-18

Views: 2346


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2658-7947 (Print)
ISSN 2686-7192 (Online)